Lupin gets FDA approval for Generic Actos

April 11, 2014 | Friday | News | By BioSpectrum Bureau

Lupin gets FDA approval for Generic Actos

Approval granted!

Approval granted!

Actos Tablets had annual US sales of US $236 million.

Lupin's Pioglitazone Tablets USP, 15 mg, 30 mg, and 45 mg are the AB-rated generic equivalents of Takeda's Actos Tablets 15 mg, 30 mg, and 45 mg and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy